Risperdal Lawyers at Bernstein Liebhard LLP Note New Study Finding...

The Firm is currently representing numerous U.S. plaintiffs in Risperdal gynecomastia claims which allege the drug was often prescribed for unapproved, off-label uses.(PRWeb January 06, 2015)Read the full story at http://www.prweb.com/releases/risperdal-lawsuit/risperdal-gynecomastia/prweb12426387.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news